Innovita Biological Technology Co., Ltd. (SHA:688253)
China flag China · Delayed Price · Currency is CNY
31.78
+1.03 (3.35%)
At close: Oct 31, 2025

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Respiratory Series
606.69M
Log In
Log In
Log In
Log In
Upgrade
Other Reagent Series
10.36M
Log In
Log In
Log In
Log In
Upgrade
Other Reagent Series Growth
7.42%
Log In
Log In
Log In
Log In
Upgrade
Eugenics Series
4.17M
Log In
Log In
Log In
Log In
Upgrade
Eugenics Series Growth
0.80%
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Equipment
159.29K
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Equipment Growth
-70.00%
Log In
Log In
Log In
Log In
Upgrade
Respiratory Tract Series - Non-COVID-19 Products
-
Log In
Log In
Log In
Log In
Upgrade
Respiratory Tract Series - Non-COVID-19 Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Respiratory Tract Series - COVID-19 Products
-
Log In
Log In
Log In
Log In
Upgrade
Respiratory Tract Series - COVID-19 Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
In Vitro Diagnostic Testing Equipment
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
China
605.76M
Log In
Log In
Log In
Log In
Upgrade
China Growth
30.28%
Log In
Log In
Log In
Log In
Upgrade
Overseas (including Hong Kong, Macau and Taiwan)
15.63M
Log In
Log In
Log In
Log In
Upgrade
Overseas (including Hong Kong, Macau and Taiwan) Growth
19.69%
Log In
Log In
Log In
Log In
Upgrade